RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization

Nature Communications

Volumn 3, Issue , 2012, Pages

  Lordier, Larissa ^a,b,c   Bluteau, Dominique ^a,b,c   Jalil, Abdelali ^b   Legrand, Céline ^a,b,c   Pan, Jiajia ^a,b,c   Rameau, Philippe ^b   Jouni, Dima ^a,b,c   Bluteau, Olivier ^a,b,c   Mercher, Thomas ^b,c   Leon, Catherine ^d,e   Gachet, Christian ^d,e   Debili, Najet ^a,b,c   Vainchenker, William ^a,b,c   Raslova, Hana ^a,b,c   Chang, Yunhua ^a,b,c  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD42 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; ISOPROTEIN; MESSENGER RNA; MYH10 PROTEIN; MYH14 PROTEIN; MYOSIN IIA; MYOSIN IIB; MYOSIN LIGHT CHAIN 2; SERINE; THREONINE; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; BLEBBISTATIN; CD34 ANTIGEN; FUSED HETEROCYCLIC RINGS; MYOSIN HEAVY CHAIN; NONMUSCLE MYOSIN TYPE IIB HEAVY CHAIN; RUNX1 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; ENDOMITOSIS; GENE SILENCING; GENETIC REGULATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MITOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYPLOIDY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TELOPHASE; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; RNA INTERFERENCE;

MAMMALIA;

ANIMALS; ANTIGENS, CD34; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTOKINESIS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; MITOSIS; MYOSIN HEAVY CHAINS; NONMUSCLE MYOSIN TYPE IIB; POLYPLOIDY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84859196315     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1704     Document Type: Article

References (43)

1. Geddis, A. E. Megakaryopoiesis. Semin. Hematol 47, 212-219 (2010).
2. Kaushansky, K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 111, 981-986 (2008). (Pubitemid 351213374)
3. Ravid, K., Lu, J., Zimmet, J. M. & Jones, M. R. Roads to polyploidy: the megakaryocyte example. J. Cell Physiol 190, 7-20 (2002).
4. Odell, T. T., Jr. & Jackson, C. W. Polyploidy and maturation of rat megakaryocytes. Blood 32, 102-110 (1968).
5. Geddis, A. E. & Kaushansky, K. Endomitotic megakaryocytes form a midzone in anaphase but have a deficiency in cleavage furrow formation. Cell Cycle 5, 538-545 (2006). (Pubitemid 43340533)
6. Lordier, L. et al Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 112, 3164-3174 (2008).
7. Geddis, A. E., Fox, N. E., Tkachenko, E. & Kaushansky, K. Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage furrow ingression followed by furrow regression. Cell Cycle 6, 455-460 (2007). (Pubitemid 46393450)
8. Papadantonakis, N. et al Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells. Cell Cycle 7, 2352-2356 (2008).
9. Schroeder, T. E. Dynamics of the contractile ring. Soc. Gen. Physiol. Ser. 30, 305-334 (1975).
10. Kunishima, S. & Saito, H. Advances in the understanding of MYH9 disorders. Curr. Opin. Hematol. 17, 405-410 (2010).
11. Leon, C. et al Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110, 3183-3191 (2007). (Pubitemid 350106310)
12. Eckly, A. et al Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 113, 3182-3189 (2009).
13. Straight, A. F. et al Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299, 1743-1747 (2003). (Pubitemid 36337202)
14. Limouze, J., Straight, A. F., Mitchison, T. & Sellers, J. R. Specificity of blebbistatin, an inhibitor of myosin II. J. Muscle Res. Cell. Motil. 25, 337-341 (2004). (Pubitemid 40941093)
15. Shin, J. W., Swift, J., Spinler, K. R. & Discher, D. E. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc. Natl Acad. Sci. USA 108, 11458-11463 (2011).
16. Kovacs, M., Toth, J., Hetenyi, C., Malnasi-Csizmadia, A. & Sellers, J. R. Mechanism of blebbistatin inhibition of myosin II. J. Biol. Chem. 279, 35557-35563 (2004). (Pubitemid 39100557)
17. Beach, J. R. & Egelhoff, T. T. Myosin II recruitment during cytokinesis independent of central s pin dlin-mediated phosphorylation. J. Biol. Chem. 284, 27377-27383 (2009).
18. Miyauchi, K., Yamamoto, Y., Kosaka, T. & Hosoya, H. Myosin II activity is not essential for recruitment of myosin II to the furrow in dividing HeLa cells. Biochem. Biophys. Res. Commun. 350, 543-548 (2006). (Pubitemid 44547882)
19. Murthy, K. & Wadsworth, P. Myosin-II-dependent localization and dynamics of F-actin during cytokinesis. Curr. Biol. 15, 724-731 (2005). (Pubitemid 40599926)
20. Bao, J., Jana, S. S. & Adelstein, R. S. Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis. J. Biol. Chem. 280, 19594-19599 (2005). (Pubitemid 41379481)
21. Takeda, K., Kishi, H., Ma, X., Yu, Z. X. & Adelstein, R. S. Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis. Circ. Res. 93, 330-337 (2003). (Pubitemid 37048245)
22. Jalagadugula, G. et al Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency. Blood 116, 6037-6045 (2010).
23. Gilles, L. et al P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1. Blood 111, 4081-4091 (2008).
24. Growney, J. D. et al Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106, 494-504 (2005). (Pubitemid 40981243)
25. Ichikawa, M. et al AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299-304 (2004). (Pubitemid 38667622)
26. Lordier, L. et al Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. Blood 116, 2345-2355 (2010).
27. Zhang, Y., Wang, Z. & Ravid, K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 271, 4266-4272 (1996).
28. Kawasaki, A. et al Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells. J. Cell. Biol. 152, 275-287 (2001). (Pubitemid 34285598)
29. Zhang, Y et al. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression. Blood 103, 3717-3726 (2004). (Pubitemid 38596287)
30. Geddis, A. E. & Kaushansky, K. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 104, 1017-1024 (2004). (Pubitemid 39038021)
31. Smutny, M. et al Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens. Nat. Cell. Biol. 12, 696-702 (2010).
32. Ubukawa, K. et al Enucleation of human erythroblasts involves nonmuscle myosin IIB. Blood 119, 1036-1044 (2012).
33. Eliades, A., Papadantonakis, N. & Ravid, K. New roles for cyclin E in megakaryocytic polyploidization. J. Biol. Chem. 285, 18909-18917 (2010).
34. Bermejo, R., Vilaboa, N. & Cales, C. Regulation of CDC6, geminin, and CDT1 in human cells that undergo polyploidization. Mol Biol. Cell. 13, 3989-4000 (2002). (Pubitemid 35398565)
35. Kohlmann, A. et al Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J. Clin. Oncol. 28, 3858-3865 (2010).
36. Owen, C. Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML). Leuk. Res. 34, 141-142 (2010).
37. Pevny, L. et al Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260 (1991). (Pubitemid 21912061)
38. Starck, J. et al Inducible Fli-1 gene deletion in adult mice modifies several myeloid lineage commitment decisions and accelerates proliferation arrest and terminal erythrocytic differentiation. Blood 116, 4795-4805 (2010).
39. Goldfarb, A. N. Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb. J. Cell. Biochem. 107, 377-382 (2009).
40. Huang, H. et al Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol Cell. Biol. 29, 4103-4115 (2009).
41. Norol, F. et al Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 91, 830-843 (1998). (Pubitemid 28078285)
42. Chang, Y et al. Proplatelet formation is regulated by the Rho/ROCK pathway Blood 109, 4229-4236 (2007). (Pubitemid 46743387)
43. Hirase, T. et al Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem. 276, 10423-10431 (2001).